The Global Market for Pain Management Drugs and Devices

Product Code BCC00143
Publication Date August 2009
Publisher BCC Research
Product Type Report
Pages 213
ISBN Number not applicable
Change currency
PDF £3,065.00 €3,691 $4,847 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

The Global Market for Pain Management Drugs and Devices

Use this report to:

  • Gain a comprehensive overview of the market for pain management, including acute versus chronic pain, new therapy trends, undertreatment, and regulatory issues
  • Understand how the aging population, reduced hospital stays, and increased home care and other forms of long-term care are infl uencing the pain management market
  • Develop business plans based on the regulatory, economic and other demand drivers for pain management products, and other prerequisites of success in these markets
  • Learn about recent advances in technology that are helping to drive growth in the pain management device market.

The global market for pain management pharmaceuticals and devices amounted to $19.1 billion in 2008 and is expected to increase to $32.8 billion in 2013. The compound annual growth rate (CAGR) for the 5-year period is projected at 11.5%.

Introduction This BCC Research report provides an overview of products included in the pain management drugs and devices market, and detailed analyses of markets and competitive environments.

The study includes information about signifi cant products, players, issues and trends, regulatory issues, and other information aff ecting the pain management industry. It provides the reader with the knowledge to adequately view and assess pain management, and the problems that the healthcare industry faces, as well as off ers insights into the market potentials. The report is designed to be a helpful business tool that will provide a thorough evaluation of the market. It addresses acute vs. chronic pain, treatments, and regulatory issues facing healthcare workers. The total pain management market includes manufacturers' revenues for pain management pharmaceuticals and pain management devices. Each of the individual segments within the various categories infl uences the total market. As demonstrated in the report, the pain management pharmaceutical category continues to generate the majority of sales throughout the forecast period. Recent advances in technology, however, are helping to drive growth in the pain management device markets.

The scope of this report is broad and includes:

  • Detailed information based on product categories, use of products, forecasts, and competitive analyses
  • The current global market status for pain management drugs and devices, with forecasts for growth through 2013
  • Coverage of specifi c trends, such as undertreatment issues, professional issues, managed care pain issues, new therapies and product pipelines, generic participation, pain research, and drug delivery
  • Company profi les.

Contents

  • Chapter One: Introduction
  • Chapter Two: Summary
  • Chapter Three: Industry Overview
    • History of Pain and Pain Treatment
    • The Perception of Pain
    • Assessment of Pain
    • How Pain Is Diagnosed
    • Thermography
    • How Pain Is Treated
    • The Aging U.S. Population
    • World Demographics
    • Life Expectancy for Men and Women
    • Incidence of Pain
    • Prevalence of Pain
    • Severe Headache or Migraine, Low Back, and
    • Neck Pain
    • Joint Pain
    • Cancer Pain
    • Pain Management in Cancer
    • HIV/AIDS Related Pain
    • Burn Pain
    • Dental Pain
    • Gender and Pain
    • Other Infl uences Determining How Pain Is Felt
    • Among Individuals
    • Obstetrics Pain
    • Orthopedic Pain
    • Pediatric Pain
    • Surgical Pain
    • Global Pain Management
  • Chapter Four: Industry Trends
    • Overview
    • Undertreatment Issues
    • Treatment of Pain and Issues Facing the Professional
    • Segment
    • Managed Care Pain Management Issues
    • Product Pipeline
    • New Developments in Breakthrough Cancer Pain
    • Opioid-induced Constipation and Reduced Compliance
    • Patent Expiration
    • Generic Participation
    • New FDA Approval Requirements for Pain Therapies
    • Future of Pain Research
    • Patient Outcomes Research
    • Drug Delivery Systems
    • Oral and Extended Release
    • Topical and Transdermal
    • Intravenous
    • Patient-controlled Analgesia
    • Iontophoresis
    • Electromechanical Transport
  • Chapter Five: Treating Pain
    • Pharmaceutical Pain Management
    • Prescription Pain Management Products
    • Analgesic Drugs
    • Non-narcotic
    • Narcotic
    • Nonsteroid Anti-infl ammatory Drugs
    • Anti-migraine Drugs
    • Antidepressant, Anticonvulsants, and Other Pain
    • Relieving Drugs
    • Anesthetics
    • General
    • Local/Regional
    • Topical
    • Over-the-counter Pain Management Products
    • Analgesic Drugs
    • Nonsteroid Anti-infl ammatory Drugs
    • Aspirin Products and Aspirin Combination Products
    • Ibuprofen and Ibuprofen Combination Products
    • Ketoprofen Products
    • Naproxen Compounds
    • Anti-migraine Drugs
    • Topical Anesthetic Drugs
    • Pain Management Devices
    • Transcutaneous Electrical Nerve Stimulators
    • Pain Tem
    • Spinal Cord Stimulators
    • Neuromuscular Stimulators
    • Other Pain Management Devices
    • Pain Management Procedures
    • Alternative Methods of Pain Management
    • Psychological Therapies
    • Biofeedback
    • Hypnosis
    • Behavior Modifi cation/Operant Conditioning
    • Relaxation and Stress Management Training
    • Imagery
    • Autogenic Training
    • Psychosocial Interventions
    • Distraction and Reframing
    • Ice
    • Warm Bath
    • Massage
    • Joint Mobilization
    • Manipulation
    • Traction
    • Acupuncture/acupressure
    • Laser Therapy
    • Surgery
    • Radiation Therapy
    • Radio Frequency Neuroablation, Epiduroscopy
    • Pain Management Services
    • Home Care
    • Hospice
    • National Hospice Organization
    • Hospitals
    • Pain Clinics
    • Skilled Nursing Facilities
  • Chapter Six: Prescription Pain Management Market
    • Size and Analysis
    • Total Market
    • Prescription Pain Markets by Product Type
    • Market Participants
    • Future Market Analysis
  • Chapter Seven: Pain Management Device Market Size
    • and Analysis
    • Total Pain Management Device Market
    • Pain Markets by Product Type
    • Market Participants
    • Future Market Analysis
  • Chapter Eight: Total Market Summary
    • Total Pain Management Market
    • Market Percentage by Product Type
  • Chapter Nine: Company Profi les
  • Selected Tables and Figures
    • Table 1 Objective Signs of Pain
    • Table 2 U.S. Population Estimates by Age Group and Gender, 1950 and 2000 (Millions)
    • Table 3 U.S. Population Projections by Age Group and Gender for Specifi c Years, 2010-2050 (Millions)
    • Table 4 World Population Growth by Geographical Region, 2008 and 2013 (Millions)
    • Table 5 Estimated and Projected World Population by Age and Gender, 2008 and 2013 (Millions)
    • Table 6 Current and Projected U.S. Life Expectancy at Birth by Gender and Year, 2000-2020 (Years)
    • Table 7 Severe Headache or Migraine, Low Back Pain, and Neck Pain Among Adults, 18 Years of Age and Over*, 1997-2009 (%)
    • Table 8 Joint Pain Among Adults 18 Years of Age and Over*, 2002-2009 (%)
    • Table 10 Estimated HIV Reported Cases by Selected Characteristics, 2007
    • Table 12 Pain by Selected Category and Gender in the 18+ U.S. Population*, 1997-2006 (%)
    • Table 13 Number of Physician Graduates from 1990- 2006 (Thousands)
    • Table 14 Number of Physicians per 100,000 Resident Population, 2006
    • Table 15 Total Number of Abuse Treatment Facilities and Clients, 2000-2007
    • Table 16 Benefi ts of Prescription Monitoring Programs for Medical Boards
    • Table 18 State Controlled Substances Scheduling Authorities and Other Contact Information
    • Table 19 Pain-management Drug Product Pipelines
    • Table 21 First Time Prescription Generic Pain Management and Approvals, January 2004-April 2009
    • Table 24 Most Commonly Used General Anesthetic Agents
    • Table 25 Acetaminophen and Acetaminophen Combination Products
    • Table 26 Aspirin and Aspirin Combination Products
    • Table 27 Ibuprofen and Ibuprofen Combination Products
    • Table 29 OTC Nonsteroid Anti-infl ammatories
    • Table 33 Worldwide Prescription Pain Management Pharmaceuticals Market, Through 2013 ($ Millions)
    • Table 34 Global Prescription Narcotic and NSAIDs Manufacturer Market Share by Manufacturer, 2008 ($ Millions)
    • Table 35 Global Prescription Anti-migraine Drug Manufacturer Market Share by Manufacturer, 2008 ($ Millions)
    • Table 36 Global Prescription Anesthesia Manufacturer Market Share by Manufacturer, 2008 ($ Millions)
    • Table 37 Global Pain Management Devices Market at Manufacturers' Sales Levels by Product Type, Through 2013 ($ Millions)
    • Table 38 Global Neuromuscular Stimulator/TENS Manufacturer Market Share by Manufacturer, 2008 ($ Millions)
    • Table 39 Global Spinal Cord Stimulator Manufacturer Market Share by Manufacturer, 2008 ($ Millions)
    • Table 40 Global Pain Management Pharmaceuticals and Devices Market by Category, Through 2013 ($ Millions)
    • Table 41 Percent Distribution of the Worldwide Pain Management Market by Segment, 2008 (%, $ Millions)
    • Figure 2 U.S. Population Estimates, by Age Group, 1950 and 2000 (Millions)
    • Figure 3 U.S. Population Estimates by Gender, 1950 and 2000 (Millions)
    • Figure 4 U.S. Population Projections, by Selected Age Group for Specifi c Years, 2010-2050 (Millions)
    • Figure 5 U.S. Population Projections, by Gender for Specifi c Years, 2010-2050 (Millions)
    • Figure 6 World Population by Geographical Region, 2008 and 2013 (Millions)
    • Figure 7 Estimated and Projected World Population by Age and Gender, 2008 and 2013 (Millions)
    • Figure 8 Current and Projected U.S. Life Expectancy at Birth by Gender and Year, 2000-2020 (Years)
    • Figure 9 Severe Headache or Migraine, Low Back Pain, and Neck Pain Among Adults, 18 Years of Age and Over*, 1997-2009 (%)
    • Figure 10 Joint Pain Among Adults 18 Years of Age and Over*, 2002-2009 (%)
    • Figure 12 Estimated HIV Reported Cases by Age Group, 2007
    • Figure 13 Estimated HIV Reported Cases by Gender, 2007
    • Figure 15 Burn Pain Management Approach
    • Figure 16 Pain by Selected Category and Gender in the 18+ U.S. Population*, 1997 and 2006 (%)
    • Figure 17 Total Number of Abuse Treatment Facilities, 2000-2007
    • Figure 19 Total Number of States with Electronic Prescription Monitoring Programs by Year of Enactment
    • Figure 20 Worldwide Prescription Pain Management Pharmaceuticals Market, 2006-2013 ($ Millions)
    • Figure 21 Global Prescription Narcotic and NSAIDs Manufacturer Market Share by Manufacturer, 2008 ($ Millions)
    • Figure 22 Global Prescription Anti-migraine Drug Manufacturer Market Share by Revenue, 2008 (%)
    • Figure 23 Global Prescription Anesthesia Manufacturer Market Share by Manufacturer, 2008 (%)
    • Figure 24 Global Pain Management Devices Market by Product Type, Through 2013 ($ Millions)
    • Figure 25 Global Neuromuscular Stimulator/TENS Unit Manufacturer Market Share by Manufacturer, 2008 (%)
    • Figure 26 Global Spinal Cord Stimulator Manufacturer Market Share, 2008 (%)
    • Figure 27 Global Pain Management Pharmaceuticals and Devices Market by Category, 2006-2013 ($ Millions)
    • Figure 28 Percent Distribution of the Worldwide Pain Management Market by Segment, 2008 (%)